Published in Biotech Law Weekly, November 17th, 2006
The Comprehensive Solution (CS) Autoplex Gene Expression Platform and the Spectral Genomics Array Comparative Genomic Hybridization (CGH) Platform provide important tools for improving gene expression validation, molecular karyotyping and genome profiling.
"With the acquisition of Spectral Genomics and our partnership with Luminex Corporation to use xMAP technology, PerkinElmer is strengthening its commitment to the genomics market," said Robert F. Friel, president of PerkinElmer Life and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.